Profil
Sheng Fu Liao is currently a Director-Supervisory Board at Yue Chang Investment Co. Ltd., Innova Health Care, Inc., and Innova Vision KK.
Previously, he served as a Director-Supervisory Board at Innova Vision Inc. He also worked as a Manager-Finance at Taiwan Mask Corp.
from 1999 to 2018.
Additionally, he was a Member-Supervisory Board at Advagene Biopharma Co., Ltd. from 2016 to 2019.
Mr. Liao is a graduate of National Cheng Kung University.
Aktive Positionen von Sheng Fu Liao
| Unternehmen | Position | Beginn |
|---|---|---|
Innova Vision KK | Direktor/Vorstandsmitglied | 17.02.2011 |
Innova Health Care, Inc. | Direktor/Vorstandsmitglied | 17.02.2011 |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Sheng Fu Liao
| Unternehmen | Position | Ende |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Direktor/Vorstandsmitglied | 23.05.2019 |
| TAIWAN MASK CORPORATION | Finanzdirektor/CFO | 15.01.2018 |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Direktor/Vorstandsmitglied | - |
Ausbildung von Sheng Fu Liao
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Taiwan Mask Corp.
Taiwan Mask Corp. SemiconductorsElectronic Technology Designs, manufactures and distributes reticles & photomasks | Electronic Technology |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | |
National Cheng Kung University
National Cheng Kung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Innova Health Care, Inc. | |
Innova Vision KK | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
















